American Century Companies Inc Bio Rad Laboratories, Inc. Transaction History

American Century Companies Inc

  • $160 Billion
  • Q2 2024

A detailed history of American Century Companies Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 5,380 shares of BIO stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,380
Previous 5,140 4.67%
Holding current value
$1.77 Million
Previous $1.78 Million 17.33%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$268.26 - $339.48 $64,382 - $81,475
240 Added 4.67%
5,380 $1.47 Million
Q1 2024

May 14, 2024
SELL
$304.11 - $351.99 $108,567 - $125,660
-357 Reduced 6.49%
5,140 $1.78 Million
Q4 2023

Feb 13, 2024
BUY
$269.37 - $365.04 $1.48 Million - $2.01 Million
5,497 New
5,497 $1.77 Million
Q3 2023

Nov 13, 2023
SELL
$350.25 - $422.63 $9.31 Million - $11.2 Million
-26,585 Reduced 87.35%
3,851 $1.38 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $5.96 Million - $8.06 Million
-16,575 Reduced 35.26%
30,436 $11.5 Million
Q1 2023

May 11, 2023
BUY
$418.69 - $503.0 $14.2 Million - $17.1 Million
34,008 Added 261.54%
47,011 $22.5 Million
Q4 2022

Feb 13, 2023
BUY
$351.71 - $456.01 $3.74 Million - $4.84 Million
10,620 Added 445.66%
13,003 $5.47 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $354,414 - $483,840
859 Added 56.36%
2,383 $994,000
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $110,353 - $142,124
238 Added 18.51%
1,524 $754,000
Q1 2022

May 11, 2022
BUY
$524.57 - $735.42 $82,882 - $116,196
158 Added 14.01%
1,286 $724,000
Q4 2021

Feb 07, 2022
BUY
$708.84 - $794.68 $204,854 - $229,662
289 Added 34.45%
1,128 $852,000
Q3 2021

Nov 10, 2021
BUY
$657.71 - $825.77 $62,482 - $78,448
95 Added 12.77%
839 $626,000
Q2 2021

Aug 05, 2021
SELL
$576.64 - $649.04 $233 Million - $263 Million
-404,837 Reduced 99.82%
744 $479,000
Q1 2021

May 14, 2021
SELL
$547.01 - $662.35 $140,581 - $170,223
-257 Reduced 0.06%
405,581 $232 Million
Q4 2020

Feb 12, 2021
SELL
$510.68 - $643.45 $91.9 Million - $116 Million
-179,979 Reduced 30.72%
405,838 $237 Million
Q3 2020

Nov 13, 2020
SELL
$454.43 - $535.6 $35.5 Million - $41.8 Million
-78,043 Reduced 11.76%
585,817 $302 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $7.62 Million - $11.2 Million
22,742 Added 3.55%
663,860 $300 Million
Q1 2020

May 14, 2020
SELL
$320.01 - $409.07 $24.8 Million - $31.7 Million
-77,535 Reduced 10.79%
641,118 $225 Million
Q4 2019

Feb 12, 2020
SELL
$319.73 - $374.2 $2.84 Million - $3.33 Million
-8,889 Reduced 1.22%
718,653 $266 Million
Q3 2019

Nov 13, 2019
SELL
$304.55 - $345.24 $6.47 Million - $7.34 Million
-21,260 Reduced 2.84%
727,542 $242 Million
Q2 2019

Aug 14, 2019
SELL
$286.93 - $312.59 $11.5 Million - $12.6 Million
-40,153 Reduced 5.09%
748,802 $234 Million
Q1 2019

May 14, 2019
BUY
$224.3 - $317.41 $22.6 Million - $32 Million
100,850 Added 14.66%
788,955 $0
Q4 2018

Feb 13, 2019
BUY
$220.1 - $309.0 $120,174 - $168,714
546 Added 0.08%
688,105 $160 Million
Q3 2018

Nov 02, 2018
SELL
$289.28 - $326.15 $1.19 Million - $1.34 Million
-4,098 Reduced 0.59%
687,559 $215 Million
Q2 2018

Aug 08, 2018
SELL
$244.1 - $303.88 $2.61 Million - $3.25 Million
-10,709 Reduced 1.52%
691,657 $200 Million
Q1 2018

May 03, 2018
BUY
$233.97 - $274.11 $25.5 Million - $29.9 Million
108,949 Added 18.36%
702,366 $176 Million
Q4 2017

Feb 02, 2018
BUY
$216.94 - $271.3 $5.91 Million - $7.38 Million
27,220 Added 4.81%
593,417 $142 Million
Q3 2017

Nov 01, 2017
BUY
$212.27 - $242.28 $120 Million - $137 Million
566,197
566,197 $126 Million

Others Institutions Holding BIO

# of Institutions
459
Shares Held
19.6M
Call Options Held
23.2K
Put Options Held
37.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email